Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

31.80 +0.21 (+0.66%)

Streaming Delayed Price Updated: 3:50 PM EDT, Mar 31, 2026 Add to My Watchlist

Price and Volume

Volume	445,575
Open	31.66
Bid (Size)	31.79 (200)
Ask (Size)	31.81 (200)
Prev. Close	31.59
Today's Range	31.21 - 31.91
52wk Range	23.91 - 38.79
Shares Outstanding	N/A
Dividend Yield	1.89%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention

March 10, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026

March 03, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Performance

YTD	-3.3%	-3.3%
1 Month	-11.1%	-11.1%
3 Month	-4.0%	-4.0%
6 Month	-10.4%	-10.4%
1 Year	+12.1%	+12.1%

More News

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026

March 02, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

February 24, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs distribution agreement with SI-BONE

February 23, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair

January 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices ↗

November 29, 2025

Via Chartmill

Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

October 27, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

UFC® and Smith+Nephew announce multi-year extension of partnership

October 22, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?

October 17, 2025

Via MarketMinute

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

October 09, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

October 03, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

October 01, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗

September 25, 2025

Via Benzinga

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

September 11, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

What Does the Market Think About Smith & Nephew? ↗

September 03, 2025

Via Benzinga

Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System

September 03, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Sterling Infrastructure Posts Better-Than-Expected Earnings, Joins Lemonade, DigitalOcean Holdings, Lattice Semiconductor And Other Big Stocks Moving Higher On Tuesday ↗

August 05, 2025

Via Benzinga

Top 2 Health Care Stocks You May Want To Dump In Q3 ↗

August 05, 2025

Via Benzinga

Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

August 05, 2025

Via Benzinga

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

July 07, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair

June 29, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures

June 24, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

June 23, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

June 18, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?

Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.

What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?

Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?

The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange

What is the current price of Smith & Nephew SNATS, Inc. Common Stock?

The current price of Smith & Nephew SNATS, Inc. Common Stock is 31.80

When was Smith & Nephew SNATS, Inc. Common Stock last traded?

The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 03/31/26 03:50 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.